Subscribe

Huafon Chemical Co., Ltd. (002064.SZ)

CNY10.33 +0.43 (+4.34%)
CN SHZ Basic Materials Chemicals - Specialty
Address No. 1788, Kaifaqu Road 325206
Wenzhou, ZJ, CN
CEO Xuanxiang Zhu
IPO 2006-08-23
ISIN CNE000001NK6

Explore sections of this company profile

Description

Huafon Chemical Co., Ltd., a Chinese enterprise established in 1999 and based in Ruian, specializes in the manufacturing and distribution of spandex. Its key product is Qianxi spandex yarn, a flexible polyurethane elastic fiber widely incorporated into diverse applications like underwear, swimwear, socks, jeans, casual athletic wear, medical bandages, fabric ribbons, and diapers. In addition to its primary spandex operations, the company also produces cyclohexanone and other benzene-based chemicals. Its business activities extend to the global trade of textile items, notably spandex fibers, and it also engages in the power and heat cogeneration sector. The firm was previously known as Zhejiang Huafeng Spandex Co., Ltd. before adopting its current name in January 2021.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
CNY10.33 +0.43 (+4.34%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
50M
Beta
0.82
Float Shares
4.95B
Free Float %
99.8%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-1.94% -2.41% -12.92% -18.53% +7.44% -8.09% +47.81% +49.12% -18.34% +132.95% +1,102.63%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
10.33
DCF (Unlevered) 9.78 -5.4%
DCF (Levered) 6.93 -32.9%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 100% Bullish
Rating 2026-05 Change
Strong Buy 1 0
Buy 2 0
Hold 0 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
5.23
Safe zone
Piotroski F-Score
6 / 9
Average
MOAT Score
1 / 10
No MOAT
Composite Rating
A-
Overall Score
4 / 5
High
DCF Score
4 / 5
High
ROE Score
4 / 5
High
ROA Score
5 / 5
High
D/E Score
2 / 5
Medium
P/E Score
2 / 5
Medium
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
  • Revenue growth Chemicals - Specialty: +4.7%
    -10.3% Q1'26: +7.2% (vs Q1'25)
  • EPS growth Chemicals - Specialty: +13.2%
    -17.8% Q1'26: +30.0% (vs Q1'25)
  • FCF margin FCF growth · Chemicals - Specialty: +44.1%
    +8.6% Q1'26: +3.7% (vs Q1'25)
  • EBIT margin Chemicals - Specialty: +8.8%
    +8.0% Q1'26: +11.6% (vs Q1'25)
  • ROIC Chemicals - Specialty: +5.6%
    +7.1% Q1'26: +11.7% (vs Q1'25)
  • Share dilution Chemicals - Specialty: +0.1%
    +0.6% Q1'26: -1.6% (vs Q1'25)
  • Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×
    1.72× Q1'26: 1.79× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.93) × ERP
WACC = 89% × Ke + 11% × Kd (4.1%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Intrinsic value (base): 9.81 Current price: 10.33
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2015
actual
Dec 2016
actual
Dec 2017
actual
Dec 2018
actual
Dec 2019
actual
Dec 2020
actual
Dec 2021
actual
Dec 2022
actual
Dec 2023
actual
Dec 2024
actual
Dec 2025
actual
Dec 2026
2 Rev. Ana.
1 EPS Ana.
Dec 2027
3 Rev. Ana.
1 EPS Ana.
Dec 2028
1 Rev. Ana.
1 EPS Ana.
Revenue
2.55B
est: 3.35B (-24.0%)
2.84B
est: 2.84B (+0.0%)
4.15B
est: 3.82B (+8.8%)
15.13B
est: 4.44B (+241.1%)
13.79B
est: 12.41B (+11.1%)
14.72B
est: 15.13B (-2.7%)
28.37B
est: 28.61B (-0.8%)
25.88B
est: 24.85B (+4.1%)
26.30B
est: 23.56B (+11.6%)
26.93B
est: 25.32B (+6.4%)
24.16B
est: 24.03B (+0.6%)
28.45B
27.99B – 28.91B
+18.4% YoY
29.84B
28.40B – 30.62B
+4.9% YoY
31.78B
30.76B – 32.46B
+6.5% YoY
EBITDA
583.78M
est: 683.38M (-14.6%)
372.09M
est: 579.81M (-35.8%)
772.18M
est: 777.77M (-0.7%)
2.88B
est: 904.27M (+218.6%)
2.70B
est: 2.53B (+6.5%)
3.44B
est: 3.08B (+11.5%)
10.12B
est: 5.83B (+73.6%)
3.81B
est: 5.07B (-24.8%)
3.69B
est: 4.80B (-23.2%)
3.82B
est: 4.71B (-18.9%)
3.46B
est: 4.47B (-22.5%)
5.29B
5.20B – 5.37B
+18.4% YoY
5.54B
5.28B – 5.69B
+4.9% YoY
5.91B
5.72B – 6.03B
+6.5% YoY
EBIT
355.43M
est: 525.68M (-32.4%)
118.48M
est: 446.01M (-73.4%)
479.65M
est: 598.29M (-19.8%)
2.26B
est: 695.60M (+225.4%)
2.08B
est: 1.95B (+7.0%)
2.60B
est: 2.37B (+9.5%)
9.16B
est: 4.49B (+104.2%)
2.76B
est: 3.90B (-29.2%)
2.41B
est: 3.69B (-34.6%)
2.32B
est: 3.48B (-33.2%)
1.93B
est: 3.30B (-41.7%)
3.91B
3.85B – 3.97B
+18.4% YoY
4.10B
3.90B – 4.21B
+4.9% YoY
4.37B
4.23B – 4.46B
+6.5% YoY
Net Income
254.13M
est: 1.43B (-82.2%)
-303.81M
est: -986.65M (+69.2%)
385.50M
est: 1.13B (-66.0%)
1.94B
est: 1.28B (+51.0%)
1.84B
est: 1.85B (-0.6%)
2.28B
est: 2.44B (-6.7%)
7.94B
est: 8.39B (-5.4%)
2.84B
est: 2.83B (+0.4%)
2.48B
est: 2.57B (-3.4%)
2.22B
est: 2.43B (-8.7%)
1.86B
est: 1.97B (-5.5%)
3.08B
2.95B – 3.17B
+56.9% YoY
3.67B
3.51B – 3.77B
+18.9% YoY
4.25B
4.07B – 4.36B
+15.8% YoY
SGA
274.83M
est: 82.08M (+234.8%)
294.23M
est: 69.64M (+322.5%)
210.98M
est: 93.41M (+125.9%)
702.85M
est: 108.61M (+547.1%)
724.35M
est: 303.90M (+138.3%)
453.14M
est: 370.43M (+22.3%)
595.68M
est: 700.47M (-15.0%)
618.33M
est: 608.58M (+1.6%)
624.33M
est: 576.79M (+8.2%)
620.16M
est: 581.60M (+6.6%)
560.29M
est: 551.95M (+1.5%)
653.47M
642.98M – 663.97M
+18.4% YoY
685.32M
652.33M – 703.40M
+4.9% YoY
730.03M
706.49M – 745.56M
+6.5% YoY
EPS
0.15
est: 0.29 (-48.3%)
-0.18
est: -0.20 (+10.0%)
0.23
est: 0.23 (+0.0%)
1.16
est: 0.26 (+346.2%)
0.43
est: 0.38 (+14.4%)
0.49
est: 0.50 (-1.0%)
1.71
est: 1.70 (+0.6%)
0.58
est: 0.57 (+1.0%)
0.50
est: 0.52 (-3.8%)
0.45
est: 0.49 (-8.2%)
0.37
est: 0.40 (-6.6%)
0.62
0.60 – 0.64
+56.9% YoY
0.74
0.71 – 0.76
+18.9% YoY
0.86
0.82 – 0.88
+15.8% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-29 A- 4/5 4/5 4/5 5/5 2/5 2/5 3/5
2026-05-28 A- 4/5 4/5 4/5 5/5 2/5 2/5 3/5
2026-05-27 A- 4/5 4/5 4/5 5/5 2/5 2/5 3/5
2026-05-26 A- 4/5 4/5 4/5 5/5 2/5 2/5 3/5
2026-05-25 A- 4/5 4/5 4/5 5/5 2/5 2/5 3/5
2026-05-22 A- 4/5 4/5 4/5 5/5 2/5 2/5 3/5
2026-05-21 A- 4/5 4/5 4/5 5/5 2/5 2/5 3/5
2026-05-20 A- 4/5 4/5 4/5 5/5 2/5 2/5 3/5
2026-05-19 A- 4/5 4/5 4/5 5/5 2/5 2/5 3/5
2026-05-18 A- 4/5 4/5 4/5 5/5 2/5 2/5 3/5
2026-05-15 A- 4/5 4/5 4/5 5/5 2/5 2/5 3/5
2026-05-14 A- 4/5 4/5 4/5 5/5 2/5 2/5 3/5
2026-05-13 A- 4/5 4/5 4/5 5/5 2/5 2/5 3/5
2026-05-12 A- 4/5 4/5 4/5 5/5 2/5 2/5 3/5
2026-05-11 A- 4/5 4/5 4/5 5/5 2/5 2/5 3/5
2026-05-08 A- 4/5 4/5 4/5 5/5 2/5 2/5 3/5
2026-05-07 A- 4/5 4/5 4/5 5/5 2/5 2/5 3/5
2026-05-06 A- 4/5 4/5 4/5 5/5 2/5 2/5 3/5
2026-04-30 A- 4/5 4/5 4/5 5/5 2/5 2/5 3/5
2026-04-29 B+ 3/5 4/5 4/5 5/5 1/5 2/5 3/5
2026-04-28 B+ 3/5 4/5 4/5 5/5 1/5 2/5 3/5
2026-04-27 B+ 3/5 4/5 4/5 5/5 1/5 2/5 3/5
2026-04-24 B+ 3/5 4/5 4/5 5/5 1/5 2/5 3/5
2026-04-23 B+ 3/5 4/5 4/5 5/5 1/5 2/5 3/5
2026-04-22 B+ 3/5 4/5 4/5 5/5 1/5 2/5 3/5
2026-04-21 B+ 3/5 4/5 4/5 5/5 1/5 2/5 3/5
2026-04-20 B+ 3/5 4/5 4/5 5/5 1/5 2/5 3/5
2026-04-17 B+ 3/5 4/5 4/5 5/5 1/5 2/5 3/5
2026-04-16 B+ 3/5 4/5 4/5 5/5 1/5 2/5 3/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
1.60B
OE per share TTM
0.32
Owner's Yield
3.20%
Maintenance CapEx ratio
2.38%
Maint CapEx / Avg PPE
46.0%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
Total invested
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock Held by 104 ETFs in our universe
# ETF Weight Est. AUM exposure TER
1 Xtrackers Harvest CSI 500 China A-Shares Small Cap ETF ASHS 0.19% 68.3K 0.65%
2 iShares MSCI China A ETF CNYA 0.11% 246.1K 0.60%
3 iShares MSCI China A UCITS ETF CNYA.L 0.10% 3.14M 0.40%
4 iShares MSCI China A UCITS ETF CNYE.MI 0.10% 103.6K 0.45%
5 Xtrackers MSCI China A UCITS ETF 1C XX2D.L 0.10% 131.6K 0.35%
6 Amundi MSCI China A UCITS ETF Acc CNAA.L 0.09% 133.4K 0.35%
7 HSBC MSCI China A UCITS ETF HMCT.L 0.09% 122.0K 0.30%
8 Xtrackers Harvest CSI A500 UCITS ETF 1D AH50.L 0.07% 11.1K 0.65%
9 JPMorgan ETFs (Ireland) ICAV - China A Research Enhanced Index Equity Active UCITS ETF JREC.L 0.05% 12.5K 0.40%
10 Invesco MSCI China All Shares Stock Connect UCITS ETF MCHN.L 0.05% 54.1K 0.35%

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
219.5K
Shares Outstanding
4.96B

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Jie Sun Financial Director & Accounting Supervisor female
Ning Xu Deputy General Manager male
Suojun Zhang Deputy General Manager male
Xiaoyin Yang Deputy General Manager male
Xuanxiang Zhu GM & Director male
Yilun Li Board Secretary female
Zhili Yu Executive Vice President male
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits